Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: “A case series”

Authors

DOI:

https://doi.org/10.5055/jom.2021.0654

Keywords:

buprenorphine, microinduction, opioid use disorder (OUD), medication-assisted treatment (MAT), opioid dependence, rapid microinduction, Bernese method

Abstract

Buprenorphine (BPN), FDA approved for opioid use disorder (OUD), requires an induction protocol for the patient in mild to moderate withdrawal. This can be problematic in outpatient practice due to complicated medical management. An emerging technique in literature uses a novel approach, called microinduction. In this method, escalating microdoses of BPN are administered, without requiring the patient to stop the opioid agonist.

Our addiction treatment center used a microdosing technique to transit patients from methadone to BPN, without requiring opioid abstinence. Our case series is novel as it was outpatient microinduction from methadone to BPN in 7 days or less.

Author Biographies

Gurpreet Singh, MBBS

Department of Psychiatry and Behavioral Sciences, University of Kansas Health System, Kansas City, Kansas

Jaya Sri Konakanchi, MBBS

School of Medicine, University of Kansas Medical Center, Kansas City, Kansas

Brandon Betsch

School of Medicine, University of Kansas Medical Center, Kansas City, Kansas

Aastha Thapa

School of Medicine, University of Kansas Medical Center, Kansas City, Kansas

Roopa Sethi, MD

Department of Psychiatry and Behavioral Sciences, University of Kansas Health System, Kansas City, Kansas

References

Wesson DR, Ling W: The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs. 2003; 35(2): 253-259.

Knopf A: SAMHSA publishes TIP 63, focusing on medications for OUD treatment. Alcohol Drug Abuse Wkly. 2018; 30(10): 6.

Bruneau J, Ahamad K, Goyer M-È, et al.: Management of opioid use disorders: A national clinical practice guideline. CMAJ. 2018; 190(9): E247-E257. DOI: 10.1503/cmaj.170958.

Cisewski DH, Santos C, Koyfman A, et al.: Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting. Am J Emerg Med. 2019; 37(1): 143-150. DOI: 10.1016/j.ajem.2018.10.013.

Ghosh SM, Klaire S, Tanguay R, et al.: A review of novel methods to support the transition from methadone and other full agonist opioids to buprenorphine/naloxone sublingual in both community and acute care settings. Can J Addict. 2019; 10(4): 41-50.

Moe J, O'Sullivan F, Hohl CM, et al.: Systematic review on effectiveness of micro-induction approaches to buprenorphine initiation. Addict Behav. 2021; 114: 106740.

Hämmig R, Kemter A, Strasser J, et al.: Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: The Bernese method. Subst Abuse Rehabil. 2016; 7: 99-105.

De Aquino JP, Fairgrieve C, Klaire S, et al.: Rapid transition from methadone to buprenorphine utilizing a micro-dosing protocol in the outpatient veteran affairs setting. J Addict Med. 2020; 14(5): e271-e273.

Published

08/01/2021

How to Cite

Singh, MBBS, G., J. S. Konakanchi, MBBS, B. Betsch, A. Thapa, and R. Sethi, MD. “Rapid Microinduction of Sublingual Buprenorphine from Methadone in an Outpatient Setting: ‘A Case series’”. Journal of Opioid Management, vol. 17, no. 7, Aug. 2021, pp. 167-70, doi:10.5055/jom.2021.0654.